Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
- PMID: 19295549
- PMCID: PMC4654626
- DOI: 10.1038/leu.2009.59
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
References
-
- Delhommeau F, Dupont S, James C, Masse A, le Couedic JP, Valle VD, et al. TET2 is a novel tumor suppressor gene inactivated in myeloproliferative neoplasms: identification of a Pre-JAK2 V617F event. ASH Annual Meeting Abstracts. 2008;112:lba-3. Late-Breaking Abstract.
-
- Tefferi A, Vardiman JW. Classification and diagnosis of myelopro-liferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008;22:14–22. - PubMed
-
- Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumours of Hematopoietic and Lymphoid Tissues. IARC Press; Lyon, France: 2001. pp. 1–351.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous